Top Story

Arterial stiffness linked to vitamin D levels in adolescent type 2 diabetes

Arterial stiffness linked to vitamin D levels in adolescent type 2 diabetes
May 28, 2015

Serum 25-hydroxyvitamin D levels were inversely associated with noninvasive measures of arterial stiffness that predict future stroke and heart attack in lean adolescents and adolescents with obesity and type 2 diabetes; however, this association was not found in adolescents with obesity alone, according to recent findings.

“The purpose of this study was to examine the relationship between serum 25-(OH)D levels in the blood and measures of arterial stiffness in youth and to determine if the relationship between 25-(OH)D levels and arterial stiffness differed in youth who were lean, obese or obese with type 2 diabetes,” the researchers wrote. “We hypothesized low serum 25-(OH)D levels would be associated with increased arterial stiffness independent of traditional cardiovascular risk factors.”

In the Journals

Puerto Rican men at greatest risk for hearing impairment, loss

May 28, 2015
Among the Hispanic population, men with Puerto Rican backgrounds, and people with diabetes or prediabetes, have increased odds of hearing impairment, according to…
Dagfinn Aune In the Journals

High-fiber diet may reduce risk for type 2 diabetes

May 28, 2015
A diet that is rich in cereal and vegetable fiber - but not fiber from fruit sources - may lower the risk for developing type 2 diabetes, according to research published…

CMS proposes updated Medicaid, CHIP-managed care regulations

May 28, 2015
CMS recently proposed a rule to update managed care regulations for Medicaid and the Children’s Health Insurance Program, according to a press release.The…
In the Journals

Experts: Weigh risks, benefits of antithyroid therapies in children with Graves’ disease

May 27, 2015
Physicians should weight the adverse effects of antithyroid therapies, which are especially increased in children, against the benefits while choosing a therapy for…
More News Headlines »
Obesity Consults

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range…
More »
Meeting News Coverage Video
VIDEO: Year in Pituitary Disease examines new developments

VIDEO: Year in Pituitary Disease examines new developments

May 20, 2015
NASHVILLE, Tenn. — In this video exclusive, Mark Molitch, MD, discusses a number of new developments in…
More »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Current Issues
View the Current Issues
morganatic-roan